UBRISA

View Item 
  •   Ubrisa Home
  • Faculty of Business
  • Management
  • Research articles (Dept of Management)
  • View Item
  •   Ubrisa Home
  • Faculty of Business
  • Management
  • Research articles (Dept of Management)
  • View Item
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Barriers of establishing profitable and sustainable pharmaceutical manufacturing firms in Botswana

    Thumbnail
    View/Open
    Molefi, Bohutsana Margaret DEC 2021 (200708043).pdf (1.547Mb)
    Date
    2021
    Author
    Molefi, Bohutsana Margaret
    Publisher
    University of Botswana, www.ub.bw
    Type
    Thesis
    Metadata
    Show full item record
    Abstract
    Africa is believed to bear a very heavy burden of disease accounting for 25% of the world’s disease statistics (Owoeye, 2014) . Modern curative care is believed to depend on the availability of medicines (World Health Organization (WHO), 2013). The African continent (including Botswana) is however dependent on pharmaceutical imports. Shortage of medicines has resuscitated the discussion on the feasibility of local production (UNDP, 2013). The few firms that attempt pharmaceutical manufacturing in Africa however, continue to close. Factors that contribute to the closure of these firms have been investigated in some African countries, there is, however, a call to conduct feasibility studies and establish why pharmaceutical manufacturing is failing in Botswana (Mhamba & Mbirigenda, 2010; Naude & Luiz, 2013; UNDP, 2016b). The purpose of this study was to establish country specific reasons that contributed to the failure of pharmaceutical manufacturing firms in Botswana. An exploratory, cross sectional study was conducted amongst firms that operated between 1990 and 2015. Two (2) employees from management from each firm were purposely sampled. Respondents completed a questionnaire which was followed by a face to face interview. Employees from four (4) of the six (6) firms responded. The data was analysed using tables, graphs and bar charts using excel to establish patterns, frequencies, and averages. Factors that presented as major challenges were poor access to markets, lack of finances, inadequate infrastructure and unskilled labour. The market was characterized by pharmaceutical registration delays, poor procurement policies and an unsupportive business environment. The use of expatriate skilled labour was still rampant and local professionals had inadequate skills to operate successful firms. Public Private Partnerships have not been successful; however, financial institutions seem to be risk averse regarding investment in the pharmaceutical industry. This research calls for a review of policies to support profitable pharmaceutical manufacturing.
    URI
    http://hdl.handle.net/10311/2486
    Collections
    • Research articles (Dept of Management) [40]

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of UBRISA > Communities & Collections > By Issue Date > Authors > Titles > SubjectsThis Collection > By Issue Date > Authors > Titles > Subjects

    My Account

    > Login > Register

    Statistics

    > Most Popular Items > Statistics by Country > Most Popular Authors